Clinical trial
Clinical Efficacy and Metabolic Impact of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Normal-weight Women With Polycystic Ovary Syndrome: a Randomized Study.
NCT01519401 is registered in ClinicalTrials.gov with Catholic University of the Sacred Heart as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy and Metabolic Impact of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Normal-weight Women With Polycystic Ovary Syndrome: a Randomized Study.
- Lead sponsor
- Catholic University of the Sacred Heart
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- July 31, 2011
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
estro-progestin drugs, polycystic ovary syndrome